# Intarcia Therapeutics funding: rounds and investors > Intarcia Therapeutics has raised $1.1B across 13 rounds since 2003. Investors include Venrock, New Enterprise Associates and New Leaf Venture Partners. Source: https://millionrounds.com/company/intarcia-therapeutics (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Intarcia Therapeutics* 13 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Valuation: $4.0B, Apr 2022 Funding summary Updated 26 Oct 2026 **$1.1B** raised across 13 rounds since 2003, from 13 sources **$43M** Series D **$50M** Series E **$50M** Series B **$9.0M** Series B **$14M** Venture **$5.0M** Series B **$46M** Debt **$46M** Debt **$50M** Debt **$160M** Series C **$200M** Growth **$225M** Growth **$215M** Round - **Latest round:** Round, $215M Sept 2016 - **Biggest round:** $225M Growth · Apr 2015 - **Investors:** 14 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2003 2005 2007 2009 2011 2013 2015 **$43M** Series D **$50M** Series E **$50M** Series B **$9.0M** Series B **$14M** Venture **$46M** Debt **$46M** Debt **$50M** Debt **$200M** Growth **$225M** Growth **$215M** Round - **First round:** Series D, $43M - **Biggest round:** $225M - **Usual gap between rounds:** 15 months ## The rounds - **Sept 2016** Round **$215M** *1 new* Lucion Venture Capital Group Reported by FinSMEs SEC filing: $184M sold, first sale Sept 2016 - **Apr 2015** Growth **$225M** No investor was named in the report. From a historical funding record - **Apr 2014** Growth **$200M** *5 new* *1 returning* [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) [Farallon Capital Management](https://millionrounds.com/fund/farallon-capital-management) [Fred Alger Management](https://millionrounds.com/fund/fred-alger-management) Quilvest Ventures From a historical funding record SEC filing: $200M sold, first sale Mar 2014 - **Nov 2012** Series C **$160M** *1 new* *2 returning* [Venrock](https://millionrounds.com/fund/venrock) [GGV Capital](https://millionrounds.com/fund/ggv-capital) [Marker](https://millionrounds.com/fund/marker) Reported by pevc.dowjones.com SEC filing: $699K sold, first sale Nov 2012 - **Nov 2012** Debt **$50M** *3 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Venrock](https://millionrounds.com/fund/venrock) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) Reported by intarcia.com SEC filing: $699K sold, first sale Nov 2012 - **Aug 2012** Debt **$46M** No investor was named in the report. Reported by sec.gov SEC filing: $46M sold, first sale Aug 2010 - **Jun 2011** Debt **$46M** No investor was named in the report. Reported by sec.gov SEC filing: $27M sold, first sale Aug 2010 - **Sept 2010** Series B **$5.0M** *3 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Venrock](https://millionrounds.com/fund/venrock) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) Reported by venturebeat.com SEC filing: $5.0M sold, first sale Aug 2010 - **May 2010** Venture **$14M** No investor was named in the report. Reported by sec.gov SEC filing: $14M sold, first sale Mar 2010 - **Jan 2010** Series B **$9.0M** No investor was named in the report. Reported by sec.gov SEC filing: $9.0M sold, first sale Nov 2009 - **Mar 2007** Series B **$50M** *3 new* *4 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Venrock](https://millionrounds.com/fund/venrock) [GGV Capital](https://millionrounds.com/fund/ggv-capital) [Alta Partners](https://millionrounds.com/fund/alta-partners) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) [Omega Funds](https://millionrounds.com/fund/omega-funds) [Quilvest Switzerland](https://millionrounds.com/fund/quilvest-switzerland) Reported by venturebeat.com - **Dec 2004** Series E **$50M** *3 new* *1 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Venrock](https://millionrounds.com/fund/venrock) [GGV Capital](https://millionrounds.com/fund/ggv-capital) [Alta Partners](https://millionrounds.com/fund/alta-partners) From a historical funding record - **Jan 2003** Series D **$43M** *1 new* [Venrock](https://millionrounds.com/fund/venrock) From a historical funding record ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2010 **Debt** 2011 **Debt** 2012 **Debt** 2012 **Series C** 2012 **Growth** 2014 **Growth** 2015 **Round** 2016 [Venrock](https://millionrounds.com/fund/venrock) [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) [GGV Capital](https://millionrounds.com/fund/ggv-capital) [Alta Partners](https://millionrounds.com/fund/alta-partners) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [Omega Funds](https://millionrounds.com/fund/omega-funds) [Marker](https://millionrounds.com/fund/marker) [Farallon Capital Management](https://millionrounds.com/fund/farallon-capital-management) ## Everyone who backed them [Venrock](https://millionrounds.com/fund/venrock) VC firm **6** rounds [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **4** rounds [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) VC firm **4** rounds [GGV Capital](https://millionrounds.com/fund/ggv-capital) VC firm **3** rounds [Alta Partners](https://millionrounds.com/fund/alta-partners) VC firm **2** rounds [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round [Foresite Capital](https://millionrounds.com/fund/forsite-capital) Private equity **1** round [Omega Funds](https://millionrounds.com/fund/omega-funds) VC firm **1** round [Marker](https://millionrounds.com/fund/marker) VC firm **1** round [Farallon Capital Management](https://millionrounds.com/fund/farallon-capital-management) Asset manager **1** round [Quilvest Switzerland](https://millionrounds.com/fund/quilvest-switzerland) Family office **1** round [Fred Alger Management](https://millionrounds.com/fund/fred-alger-management) Growth equity **1** round Lucion Venture Capital Group no record of our own yet **1** round Quilvest Ventures no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=intarcia-therapeutics). ## Also claim to have backed them These 2 firms list Intarcia Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [The Pritzker Organization](https://millionrounds.com/fund/the-pritzker-organization) Family office Per its own site [Cloudstone Venture...](https://millionrounds.com/fund/cloudstone-venture) VC firm Per its own site ## Quick answers about Intarcia Therapeutics ### Who invested in Intarcia Therapeutics? Intarcia Therapeutics's investors include Venrock, New Enterprise Associates, New Leaf Venture Partners, GGV Capital and Alta Partners, and 9 more on record. ### How much has Intarcia Therapeutics raised? Intarcia Therapeutics has raised $1.1B across 13 rounds since 2003. ### When did Intarcia Therapeutics last raise? Intarcia Therapeutics's most recent round was an Undisclosed round of $215M in Sept 2016. ### What was Intarcia Therapeutics's biggest round? Intarcia Therapeutics's largest round on record is $225M (Growth), in Apr 2015. ### Who backed Intarcia Therapeutics first? Intarcia Therapeutics's first round on record, in Jan 2003, was backed by Venrock. ### What stage is Intarcia Therapeutics at? Intarcia Therapeutics's latest named round is an Undisclosed round, in Sept 2016. ### Where is Intarcia Therapeutics based? Intarcia Therapeutics is based in the United States. ## Companies like Intarcia Therapeutics In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app